Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
44.00    0.00 (0.00%)
Bid:
43.00
Ask:
45.00
Spread: 2.00 (4.651%)
Market Cap: £26.10m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Half Year Trading Update

18 Jul 2024 07:00

RNS Number : 8454W
KRM22 PLC
18 July 2024
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Half Year Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company with a particular focus on risk management in capital markets, today issues the following trading update for the six months ended 30 June 2024 (the "Period") which is in line with management's expectations.

The Company has continued to make good progress in the Period increasing the value of its Annual Recurring Revenue ("ARR") from £5.4m at the end of FY 2023 to £6.0m at the end of the Period and, as at the date of this announcement, the Company's ARR has further increased to £6.1m.

The Company expects to report results for the Period in September 2024, and these are estimated to be:

· ARR: £6.0m (H1 2022: £5.0m)

· Total revenue: £3.3m (H1 2023: £2.4m)

· Adjusted EBITDA: £0.3m (H1 2023: loss of £1.0m)

· Cash balance as at 30 June 2024: £0.6m (FY 2023: £0.9m)

· Net debt at 30 June 2024: £3.9m (FY 2023: £3.6m)

 

A total of £1.1m of new ARR was generated in the Period through both sales to new customers, new product sales to existing customers and contractual price increases. Sales of the Limits Manager product has continued and KRM22 now has ARR contracts in place for its Limits Manager product with nine Futures Commission Merchants ("FCMs"), of which four have been signed in the Period, with two contracts through direct sales, one contract through the distribution agreement with Trading Technologies International, Inc. ("TT") and one additional contract which was originally entered into through the TT distribution agreement and subsequently transferred to KRM22. The Company did see customer churn of £0.4m in the Period, primarily from three customers for the Market Surveillance product, Post-Trade Stress product and one customer with multiple products who terminated their contract as they were closing their futures trading desk.

The Company has a strong pipeline of sales opportunities for the Limits Manager product. Risk Manager, which combines the legacy At-Trade and Post-Trade products, together with new functionality, is creating additional new sales opportunities with both new and existing customers.

As announced in the February 2024 trading update, the Company implemented a focused cost savings program with annual cost savings of approximately £1.2m. This decisive action, together with the increase in total revenue recognised in the Period compared with H1 2023 and the continued careful management of the underlying cost base of the business, has contributed to the Company reporting an adjusted EBITDA profit for the period of £0.3m. The Company has benefited from one-off non-recurring revenue being recognised in the Period meaning that management expectations for the full year outturn remain unchanged.

The Company's cash balance of £0.6m, together with the availability of £0.5m, which remains undrawn, under the TT convertible loan, means that the Company expects to continue to operate within its existing cash and debt facilities. However, the Board remains focused on careful cash management as it enters the second half of the year.

Dan Carter, CEO of KRM22, commented: "KRM22 has had strong first half of 2024 with ARR now at £6.1m and, with a substantial pipeline of sales opportunities through the remainder of the year and in to 2025, this growth is expected to continue as we drive towards our target of becoming a £10.0m ARR business."

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Garry Jones, Non-Executive Chairman

Dan Carter, CEO

Kim Suter, CFO

 

Cavendish Capital Markets Limited (Nominated Adviser and Broker) +44 (0)20 7220 0500

Carl Holmes / George Dollemore (Corporate Finance)

Sunila de Silva (ECM)

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at www.krm22.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFMEFWELSEEW
Date   Source Headline
1st Dec 20237:00 amRNSIssue of Restricted Stock Units
26th Sep 20237:00 amRNSInterim Results
27th Jul 202311:48 amRNSResult of General Meeting
21st Jul 20237:00 amRNSDirector Dealing
20th Jul 20237:00 amRNSHalf Year Trading Update
4th Jul 20237:00 amRNSPosting of Accounts, Circular and Notice of GM
30th Jun 202312:41 pmRNSResult of AGM
27th Jun 20237:00 amRNSFinal Results
19th Jun 20237:00 amRNSNew Debt Facility
8th Jun 20237:00 amRNSAnnual Report and Notice of AGM
16th Dec 20223:15 pmRNSIssue of Options
20th Sep 20227:00 amRNSInterim Results
13th Jun 202210:00 amRNSHolding(s) in Company
5th May 202212:00 pmRNSResult of AGM
20th Apr 20222:30 pmRNSDirector Dealing
12th Apr 20227:00 amRNSNotice of AGM and Posting of Annual Report
7th Apr 20224:30 pmRNSHolding(s) in Company
28th Mar 20225:30 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSProduct Launch Under Distribution Agreement
1st Mar 20227:00 amRNSUpdate re Annual Results (Change of Date)
31st Jan 20227:00 amRNSTrading Update
5th Jan 202210:47 amRNSHolding(s) in Company
30th Dec 20219:47 amRNSSubscription Completion, Executive Changes and TVR
22nd Dec 20217:00 amRNSSubscription Update
22nd Nov 20217:00 amRNSHolding(s) in Company
1st Nov 20217:00 amRNSSubscription Agreement and Trading Update
20th Oct 20213:43 pmRNSHolding(s) in Company
16th Sep 20212:38 pmRNSDirector/PDMR Shareholding
13th Sep 20219:52 amRNSDirector/PDMR Shareholding
10th Sep 20212:48 pmRNSDirector/PDMR Shareholding
8th Sep 202112:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
1st Sep 20217:00 amRNSInterim Results
30th Jul 20217:00 amRNSContract Extension
22nd Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20217:00 amRNSKRM22 announces partnership with Waymark Tech
28th Apr 20211:29 pmRNSResult of AGM
19th Apr 20217:00 amRNSExercise of options and total voting rights
26th Mar 20213:24 pmRNSHolding(s) in Company
23rd Mar 20218:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20215:39 pmRNSHolding(s) in Company
16th Mar 202111:06 amRNSTechnology Demonstration
16th Mar 20217:00 amRNSFinal Results
24th Feb 20217:00 amRNSKRM22 announces new partnership
20th Jan 20217:00 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSIssue of Options
12th Jan 20217:00 amRNSTrading Update
5th Oct 20207:00 amRNSIssue of Options
21st Sep 20208:33 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.